iShares Bitcoin Trust ETF

Increase my SL and added more.

Pump till 17 Sep, targeting $47-$49, will add more as long 4hr previous low hold. IMO….✌🏼

DYOR/NFA

$BTC/USD(BTCUSD.HAS)Saylor is back buying 4603 BTC after 2 months.

🌟🌟🌟Bitcoin didn't just move. It roared. One clean macro spark, one brutal short squeeze and suddenly the entire crypto market is staring at USD80,000.

What just happened?

This wasn't just luck. This was liquidity, policy and raw demand colliding at the same moment.

The single biggest catalyst was the US Treasury doubling long dated bond buybacks from USD 2 billion to at least USD 4 billion per operation with potential deployment of USD 950 billion from the US Treasury General Account. This pushed yields lower. Lower yields means lower opportunity cost of holding Bitcoin.

Then there is President Trump urging Congress to accelerate the Clarity Act.

Can Bitcoin go further? Yes. The key resistance zone is between USD 81,250 to USD 83,000. A good strategy to get into Bitcoin is to buy $iShares Bitcoin Trust ETF(IBIT.US). iBit is the largest spot Bitcoin ETF with assets under management of USD 47.5 billion, controlling 61% of all Bitcoin held across US spot ETFs.

It is time to get back into Bitcoin as crypto winter is over.

$XTALPI(02228.HK)

Based on the aforementioned in-depth research, we present a clear core conclusion:

The current timing calls for [maintaining positions] (and adding to positions at dips during volatile pullbacks / optimizing portfolio structure), rather than systematically reducing exposure.

The Hong Kong innovative medicine sector has completed industrial clearing and undergone a fundamental qualitative shift, entering a golden window period of advancing from historically extremely low valuations to an earnings-driven upward cycle. The core supporting logic for this judgment is as follows:

1. Valuation is at an absolute bottom; downside risk is locked in (high payoff ratio)

The valuation discount for Hong Kong biopharma assets has reached extreme historical levels. Currently, the price-to-sales ratio (PS-TTM) for Hang Seng Tech and related biotech assets is approximately 2.3x, and the P/E ratio (PE-TTM) is around 20x, both sitting in the bottom 10% of their five-year historical percentiles. Current secondary market prices have already priced in extreme pessimism regarding geopolitical frictions and macro liquidity disturbances. The risk of further significant compression in valuations is very limited, providing a solid margin of safety.

2. Industry fundamentals have crossed the break-even line; endogenous cash-generating capability is established (high certainty)

In contrast to the past phase of relying on external financing to "burn cash and paint pie charts," leading Chinese innovative drug companies have fully entered a "period of earnings realization" supported by actual sales revenue and cash flow:

Alright, AI has found me reasons to hold. I'll close my eyes and ignore XtalPi, shifting my attention back to the great crypto circle $iShares Bitcoin Trust ETF(IBIT.US) $IShares Ethereum Trust ETF(ETHA.US)

$iShares Bitcoin Trust ETF(IBIT.US) will be looking at price action: 50% retracement before start dca. IMO still uncertain if the bottom its in, waiting for Sept for confirmation. For now will monitor.

🌟🌟🌟If you are looking for proof that Crypto Winter has melted, the fundamental data points to 3 catalysts:

1. Bitcoin spot price has jumped, hitting a USD 72,500 baseline.

2. The Clarity Act has gained traction in the US Congress.

3. The world's largest asset managers including BlackRock, Visa, Mastercard and DTCC are actively launching institutional tokenisation infrastructure. With real world assets, corporate bonds and money market funds being absorbed in the blockchain pipeline, the technological foundation of global finance is being permanently rewritten.

$iShares Bitcoin Trust ETF(IBIT.US)is a good way to get back into the crypto market. It tracks the physical spot price of Bitcoin and its fund manager is BlackRock, the largest asset manager in the world.